Comparison of periprocedural and long term outcomes of proximal versus distal cerebral protection method during carotid artery stenting


Gul Z. B., Akkaya E., Vuruskan E., Akgul O., PÜŞÜROĞLU H., SÜRGİT Ö., ...Daha Fazla

Vasa - European Journal of Vascular Medicine, cilt.44, sa.4, ss.297-304, 2015 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 4
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1024/0301-1526/a000445
  • Dergi Adı: Vasa - European Journal of Vascular Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.297-304
  • Anahtar Kelimeler: Proximal flow blockage protection system, distal protection with a filter, major adverse cerebral and cardiovascular events
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: Th e aim of this study was to assess the periprocedural and one-year outcomes of two diff erent cerebral protection systems used during carotid artery stenting (CAS). Patients and methods: We enrolled 90 consecutive patients with carotid artery stenosis who underwent CAS with a proximal fl ow blockage protection system (mean age 69.7 ± 8) or distal protection with a fi lter (mean age 70.8 ± 7). Results: CAS was performed successively on 89 patients (99 %). Adverse events were defi ned as major stroke, minor stroke, transient ischemic attack (TIA), myocardial infarction, and death. Two strokes, one TIA, one death, and one myocardial infarction were observed in-hospital. Th ere were no signifi cant diff erences in safety or benefi ts between the proximal fl ow blockage embolic protection system (n = 45) and the distal fi lter protection system (n = 45) in terms of clinically apparent cerebral embolism, TIA, death, or myocardial infarction during the periprocedural stage or during the one-year follow-up period. Conclusions: Although it has been shown that the proximal fl ow blockage cerebral protection system decreases the risk of silent cerebral embolism, it has no advantage over the distalfi lter protection system in terms of adverse cerebrovascular or cardiac events during the periprocedural stage or during the long-term follow-up period.